Clinical Impact of Point-of-Care vs Laboratory Measurement of Anticoagulation

Autor: Linda Schwartz, Rubina Sunderji, Kenneth Gin, Keith Chambers, Anthony Fung, Cedric J. Carter, Cheryl Davies, Karen F. Shalansky

Publikováno v: American Journal of Clinical Pathology. 123:184-188

Patients using anticoagulation point-of-care (POC) monitors are advised to periodically test these systems against laboratory methods to monitor performance. The international normalized ratio (INR), however, can vary between test systems owing to di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4759b24b95290331672a9126febbe52f
https://doi.org/10.1309/p2y3vm4axpvudaw3

Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke

Autor: Susan C. Fagan, Rubina Sunderji, Luciana Frighetto, Shannon E. Sinclair, Peter Loewen, Philip Teal, Carlo A. Marra

Publikováno v: PharmacoEconomics. 19:927-936

Background: There are over 40 000 ischaemic strokes annually in Canada, which result in significant morbidity, mortality and burden to the healthcare system. A recent, large clinical trial has evaluated tissue plasminogen activator (t-PA) intravenous

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e15aec66356e55c7b8a700b9dbc44330
https://doi.org/10.2165/00019053-200119090-00004

Outpatient Self-Management of Warfarin Therapy: A Pilot Study

Autor: Kenneth Gin, Lara Campbell, Rubina Sunderji, Karen F. Shalansky, Cedric J. Carter, Anthony Fung

Publikováno v: Pharmacotherapy. 19:787-793

Self-testing and adjusting of warfarin dosages by patients is an evolving strategy for management of oral anticoagulation. We performed this open, prospective, 3-month pilot study to assess the feasibility of conducting a large, randomized trial comp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6aa8f1904a78971061755aa4d85e1c
https://doi.org/10.1592/phco.19.9.787.31546

Self-monitoring of oral anticoagulation: Systematic review and meta-analysis of individual patient data

Autor: Robert Edson, Artur Bernardo, Heinrich Körtke, Josep M. García-Alamino, Otto Wagner, Kairen Bradford, Pablo Alonso-Coello, Carl Heneghan, Rubina Sunderji, Tayyaba Khan, Michael Hasenkam, Juan Carlos Souto, Scott Kaatz, Richard Stevens, Clare Bankhead, Andrea Siebenhofer, Kenneth Gin, Marcel Levi, David Fitzmaurice, Alison Ward, Heinz Völler, Jack Ansell, Alice Fuller, M. E. Cromheecke, Bárbara Menéndez-Jándula, Farhad Kamali, S Tyndel, Christian Schaefer, Rafael Perera, Karen F. Shalansky, Ivo Rakovac, Alain Gadisseur, Alan K. Jacobson, Rebecca J. Beyth, David B. Matchar, Armin Zittermann, Chris Gardiner, Eve Knight, Thomas Christensen

Publikováno v: Lancet, 379(9813), 322-334. Elsevier Limited
Heneghan, C, Ward, A, Perera, R, Bankhead, C, Fuller, A, Stevens, R, Bradford, K, Tyndel, S, Alonso-Coello, P, Ansell, J, Beyth, R, Bernardo, A, Christensen, T D, Cromheecke, M E, Edson, R G, Fitzmaurice, D, Gadisseur, A P A, Garcia-Alamino, J M, Gardiner, C, Hasenkam, M, Jacobson, A, Kaatz, S, Kamali, F, Khan, T I, Knight, E, Körtke, H, Levi, M, Matchar, D, Menéndez-Jándula, B, Rakovac, I, Schaefer, C, Siebenhofer, A, Souto, J C, Sunderji, R, Gin, K, Shalansky, K, Völler, H, Wagner, O, Zittermann, A & Self-Monitoring Trialist Collaboration 2012, ' Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data ', Lancet, vol. 379, no. 9813, pp. 322-34 . https://doi.org/10.1016/S0140-6736(11)61294-4
The lancet : international edition

Summary Background Uptake of self-testing and self-management of oral anticoagulation has remained inconsistent, despite good evidence of their effectiveness. To clarify the value of self-monitoring of oral anticoagulation, we did a meta-analysis of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aaf38823a8464375da5f0c93341679c
http://ora.ox.ac.uk/objects/uuid:4da8e79f-e571-4b11-9908-5701f48808d4

Glycoprotein IIb/IIIa inhibitors in patients with end-stage renal disease

Autor: Eric J Villeneuve, Rubina Sunderji

Publikováno v: The Annals of pharmacotherapy. 39(4)

OBJECTIVE: To determine whether glycoprotein IIb/IIIa inhibitors (GPIs) are effective and safe as adjunctive therapy for percutaneous coronary intervention (PCI) in patients with end-stage renal disease (ESRD). DATA SOURCES: MEDLINE (1966–June 2004

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b501f59cfd0b92c84ab9eb5f253c4c4e
https://pubmed.ncbi.nlm.nih.gov/15728329